Ruben, Baby Girl D.
HRN: 23-73-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/16/2023
09/22/2023
IVT
48mg
Q24
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes